Acorda Therapeutics, Inc.
ACORDelisted Apr 25, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001008848
Acorda Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Jun 23, 2023; 17 institutions reported holding it in 13F filings for Q1 2024, worth $2.13M in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Acorda Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 37 | 37 | 0 |
| Shares | 3.70M | 3.79M | +87.7K (+2.4%) |
| Value | $18.0M | $18.1M | +$52.0K (+0.3%) |
New holders (7)
Institutions that held Acorda Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Squarepoint Ops LLC | 49,269 | $235.0K | 0.00% |
| Citadel Advisors LLC | 44,666 | $213.0K | 0.00% |
| State Street Corp | 31,648 | $151.0K | 0.00% |
| United Asset Strategies, Inc. | 27,100 | $129.0K | 0.02% |
| HN Saltoro Capital, LP | 11,853 | $57.0K | 0.06% |
| Virtu Financial LLC | 10,119 | $48.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 100 | $0 | 0.00% |
Sold out (7)
Institutions that held Acorda Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Chilton Capital Management LLC | 63,781 | $311.0K |
| QS Investors, LLC | 50,801 | $247.0K |
| Public Employees Retirement System of Ohio | 21,913 | $107.0K |
| Simplex Trading, LLC | 5,544 | $26.0K |
| Bank of Montreal | 1,800 | $8.00K |
| South Dakota Investment Council | 1 | $0 |
| Private Capital Group, LLC | 10 | $0 |